TRIM21 as a potential prognostic biomarker and therapeutic target affects the growth of pancreatic cancer
{{output}}
Background: Pancreatic cancer is called “the king of cancer” because of its high degree of malignancy, poor prognosis, and lack of effective treatment. It encompasses multiple subtypes, with pancreatic adenocarcinoma (PAAD) rep... ...